Diagnosis
H&P
Diagnosis is clinical.
Risk Factors:
Common presentation:
DDx
Treatment
Mild to moderate disease: Topical treatments – corticosteroids, vitamin D analogs (calcipotriene and calcitriol), tazarotene, calcineurin inhibitors
Severe psoriasis: Phototherapy, systemic medications; Biologics (including TNF inhibitors)
–Systemic drugs: Acitretin (Soriatane), Adalimumab (Humira), Cyclosporine (Sandimmune), Etanercept (Enbrel), Infliximab (Remicade), Methotrexate, Ustekinumab (Stelara)
Background
Reference
http://www.aafp.org/afp/2013/0501/p626.html